FDA approves new painkiller that shows promise and challenges of opioid alternatives
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
FDA Approves the First Non-Opioid Pain Drug in 20 Years
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
F.D.A. Approves Drug to Treat Pain Without Opioid Effects
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...
Armed robbery in Revesby4h
Brazilian Scientists Map Brain Malformation in Epilepsy
Using a single-cell sequencing technique, Brazilian researchers have created the first cell atlas of focal cortical dysplasia ...
fingerlakes14h
New brain circuit discovery may improve anxiety treatment
Weill Cornell Medicine researchers have identified a brain circuit linked to anxiety that may provide a new drug target, ...
Next-generation tau radiotracers outperform FDA-approved imaging agents in detecting Alzheimer's disease
Two new PET radiotracers have outperformed the only current Food and Drug Administration (FDA) approved radiotracer for ...
Advanced brain circuit-mapping technique reveals new anxiety drug target
Weill Cornell Medicine investigators have identified in a preclinical model a specific brain circuit whose inhibition appears ...
Medscape1d
Alzheimer’s Disease: The Cholinergic Revival
A pathway once considered fundamental in Alzheimer’s disease is being studied intensely again, and may soon result in safer, ...
New Atlas1d
Younger cannabis users have reduced brain function, finds largest study yet
The largest study yet into the effects of cannabis on the brains of 18- to 36-year-olds has found that the drug can reduce ...